Ken Keller
About
Ken Keller is from Basking Ridge, New Jersey, United States. Ken is currently President and Chief Executive Officer and Head of the Global Oncology Business Unit at Daiichi Sankyo, Inc., located in Basking Ridge, New Jersey, United States.
Ken Keller's contact information is available for free on finalscout.com, a web-based professional networking database with more than 500 million business contacts and 200 million company profiles.
Ken Keller's current jobs
As President and CEO of Daiichi Sankyo, Inc., Ken is responsible for leading the transition of the organization into the Oncology therapeutic specialty. Under his leadership Daiichi Sankyo has successfully obtained approval of its first two oncology products , ENHERTU in MBC and TURALIO in TGCT, a rare bone cancer . As CEO responsible for administrative and commercial organization, including sales, marketing, managed Care, Regulatory , HR, Supply chain, finance, medical affairs, IT, business development, legal and compliance. Ken is accountable for the P&L, which generates multi billions in revenue and profits. Total head count exceeds N=2000. He is a member of the Global General Management Committee, Daiichi Sankyo Inc. Board of Directors and American Regent Inc. Board of Directors. Co-chair of Joint Steering Commitee with respective President/CEO for multiple external partnerships e.g. Lilly,Astra-Zeneca. Member of the Pharma Board of Directors.